BDNF and depressive symptom measurement: Given the known role of BDNF in pain modulation, especially its role as a defense mechanism for pain, we surmised that the decreased serum BDNF after treatment in the FM patients could be related to pain modulating, not the improvement in depression and related neuroplasticity, because depression improvement needs more time and higher dose of antidepressants.